We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Ferrite Nanoparticles for Hyperthermic Cancer Therapeutics

By LabMedica International staff writers
Posted on 08 Nov 2017
Print article
A novel type of nontoxic magnetic nanoparticles shows potential for treating malignant tumor cells through controlled hyperthermia.

For hyperthermia to be used under clinical conditions for cancer therapeutics the temperature regulation needs to be precise and accurately controllable. In the case of the metal nanoparticles used for such activities, a high coercivity is a prerequisite in order to couple more energy in a single heating cycle for efficient and faster differential heating. Coercivity is a measure of the ability of a ferromagnetic material to withstand an external magnetic field without becoming demagnetized.

Ferromagnetic materials with high coercivity are called magnetically hard materials, and are used to make permanent magnets. Materials with low coercivity are said to be magnetically soft. The latter are used in transformer and inductor cores, recording heads, microwave devices, and magnetic shielding.

Chemically stable Co–Zn ferrite nanoparticles have typically not been used in self-regulating hyperthermia temperature applications to date due to their low Curie temperature (the temperature at which certain materials lose their permanent magnetic properties), usually accompanied by a poor coercivity.

Tumor cells can be attacked and killed by hyperthermic nanoparticles without affecting normal tissue if the temperature of the particles can be controlled accurately within a range of 42°C to 45°C. To accomplish this task, investigators at the University of Surrey (United Kingdom) developed novel Cr3+ substituted Co–Zn ferrite nanoparticles, whose Curie temperature was 45.7 °C. Under clinically acceptable magnetic field conditions, the temperature of these nanoparticle suspensions could be self-regulated to 44.0°C.

The investigators reported in the October 7, 2017, issue of the journal Nanoscale that evaluation of the in vitro cytotoxicity of the nanoparticles showed a low toxicity, which indicated that this novel set of magnetic nanoparticles should be appropriate for use in self-regulating hyperthermia therapeutics.

Senior author Dr. Ravi Silva, head of the advanced technology institute at the University of Surrey, said, "This could potentially be a game changer in the way we treat people who have cancer. If we can keep cancer treatment sat at a temperature level high enough to kill the cancer, while low enough to stop harming healthy tissue, it will prevent some of the serious side effects of vital treatment. It is a very exciting development which, once again, shows that the University of Surrey research is at the forefront of nanotechnologies - whether in the field of energy materials or, in this case, healthcare."

Related Links:
University of Surrey

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.